Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat

  • 2017-03-07
  • Scientific Reports 7(1)
    • E. Patterson
    • E. Patterson
    • R. Wall
    • R. Wall
    • Sara Lisai
    • R. Ross
    • T. Dinan
    • J. Cryan
    • G. Fitzgerald
    • S. Banni
    • E. Quigley
    • F. Shanahan
    • C. Stanton
    • C. Stanton

Study Design

Type
Randomized Controlled Trial (RCT)
Population
BALB/c mice
Methods
Controlled experimental study

Abstract

This study focused on the mechanisms that fatty acid conjugating strains - Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 - influence lipid metabolism when ingested with α-linolenic acid (ALA) enriched diet. Four groups of BALB/c mice received ALA enriched diet (3% (w/w)) either alone or in combination with B. breve NCIMB 702258 or B. breve DPC 6330 (109 CFU/day) or unsupplemented control diet for six weeks. The overall n-3 PUFA score was increased in all groups receiving the ALA enriched diet. Hepatic peroxisomal beta oxidation increased following supplementation of the ALA enriched diet with B. breve (P < 0.05) and so the ability of the strains to produce c9t11 conjugated linoleic acid (CLA) was identified in adipose tissue. Furthermore, a strain specific effect of B. breve NCIMB 702258 was found on the endocannabinoid system (ECS). Liver triglycerides (TAG) were reduced following ALA supplementation, compared with unsupplemented controls (P < 0.01) while intervention with B. breve further reduced liver TAG (P < 0.01), compared with the ALA enriched control. These data indicate that the interactions of the gut microbiota with fatty acid metabolism directly affect host health by modulating n-3 PUFA score and the ECS.

Research Insights

    Back to top